# Protalix BioTherapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2020

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 10-Q/A
- Filed: 2020-06-01
- Accepted by EDGAR: Jun 1, 2020, 17:20 ET
- Period: 2020-03-31
- Accession: 0001104659-20-068485
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000110465920068485/tm2014552d3_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000110465920068485/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000110465920068485/tm2014552d3_10qa.htm

Filed Jun 1, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-068485. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
